Drug pricing, patent losses and deals: Here's what pharma execs see ahead in the industry - CNBC
Source:CNBC
Big pharma is grappling with new drug pricing deals and roughly $300 billion in potential lost revenue from patent expirations of blockbuster drugs.
Related Articles
2027 Mercedes-Benz S-Class Is a Rolling Supercomputer With Heated Seatbelts - The Drive
If it sounds high-tech and maybe even a bit complicated, it’s because it is. But also, the …
BlackRock’s Rick Rieder surges in Federal Reserve chair race - Financial Times
Donald Trump has said he plans to name his nominee to run the US central bank ‘in the not too …
Autosteer Out: Tesla Stock (NASDAQ:TSLA) Slips as Lesser Trims Lose Autosteer Systems - TipRanks
Full Self-Driving (FSD) is both the goal and the marquee offering at electric vehicle giant Tesla …
Column | I let ChatGPT analyze a decade of my Apple Watch data. Then I called my doctor. - The Washington Post
I gave the new ChatGPT Health access to 29 million steps and 6 million heartbeat measurements. It …